MARKET NEWS AND UPDATES.
Get notified for Latest News and Market Alerts.
Get notified for Latest News and Market Alerts.
×
CMP as on 17-Aug-22 15:59
₹ 233.50Open
₹ 232.40Turnover (lac)
₹ 869Prev. Close
₹ 231.05Day's Vol (shares)
₹ 3,72,004CMP as on17-Aug-22 15:29
₹ 233.80Open
₹ 234.90Turnover (lac)
₹ 37Prev. Close
₹ 231.00Day's Vol (shares)
₹ 27,049Wockhardt initiates Phase 3 global clinical study of its novel antibiotic WCK 5222
WCK 5222 is a super-drug, an entirely new class of antibiotic known as -lactam ENHANCER.
The novel antibiotic WCK 5222 is a Super-drug which is entirely a new class of antibiotic known as &946;-lactam ENHANCER.
On 12 August 2022
On 12 August 2022
Deepak will assume the position of Pramod Gupta who has extended his resignation to the company citing health issues.
Mr. Gupta is a qualified Chartered Accountant.
With immediate effect
In view of the above, the paid-up equity share capital of the Company has increased from Rs55,40,77,515/- (11,08,15,503 equity shares o
Wockhardt surged 9.51% to Rs 320.05 after the company and Serum Life Sciences UK announced collaboration for manufacturing multiple vac
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity
